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1. Introduction 
Periodontal diseases (gingivitis and periodontitis) are inflammatory processes that involve 
the supporting tissues of the teeth. According to a currently used classification (Armitage, 
1999), gingival diseases can be divided into four major groups: (1) dental plaque-induced 
gingival diseases, (2) gingival diseases modified by systemic factors, (c) gingival diseases 
modified by medication, and (4) gingival diseases modified by malnutrition. Plaque-
induced gingivitis is the most common form of the periodontal diseases, affecting a 
significant proportion of the world population. The periodontal tissues react to the presence 
of bacteria with an inflammatory immune response. In the initial phase, components of the 
non-specific immune system play a main role while an efficient response of the tissues to the 
infection depends on a selective but not very specific recognition system. It is mainly based 
on the detection of chemical structures that are present on the surface of many different 
microorganisms, but do not occur on the surface of cells of the body. After recognition of 
these structures, the effector mechanisms of cells (e.g. macrophages, neutrophil 
granulocytes, etc.) are triggered and humoral systems (such as complement) are activated. 
The mechanisms of non-specific immunity neutralize and eliminate harmful products 
generated by pathogenic microorganisms and subsequently help regenerate the damaged 
tissues (Shapira et al., 2005). In the healthy periodontium, pathogenic bacteria are removed 
either mechanically (tongue movements, chewing of food, secretion of saliva, separation of 
epithelial cells) and also by production of gingival crevicular fluid. This fluid plays an 
important role in the defense mechanisms as it contains a number of proteins and cells 
whose composition depends on the inflammatory stage. A protection barrier between the 
plaque and the epithelium formed by neutrophil leukocytes in the sulcus area impedes 
bacterial penetration into the deeper tissue structures (Ohlrich et al., 2009). If bacteria 
penetrate subepithelially, due to a chemotactic action of the substances released by the 
bacteria and activated by cells of the affected tissue, the migration process of further cells 
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into the junctional epithelium and gingival sulcus increases. Mediators of leukocytes, 
together with the activated complement components, kinin system and products of 
arachidonic acid further amplify the inflammatory response leading to a widening of 
intercellular spaces between the cells of the junctional epithelium, which allows increased 
diffusion of bacterial products into the gingival tissues. In the early phase, lymphocytes 
begin to accumulate, at first T lymphocytes and activated macrophages predominate in the 
inflammatory infiltrate, in the late chronic (or established) phase a change to B lymphocytes 
and plasma cells is apparent (Seymour et al., 1988). Proliferation of the junctional epithelium 
spreads apically and laterally. If the process goes on untreated, the periodontal ligament and 
alveolar bone are destructed and a periodontal pocket forms. However, it must be noted 
that the pathological process does not always proceed at the same intensity; there are phases 
of acute exacerbation and chronic stagnation alternate.  
In the 1960s experimental gingivitis studies (Loe et al., 1965) demonstrated that gingivitis is 
the response of the body to the build-up of dental plaque. These studies also showed a 
substantial variation in this response in different individuals some people taking longer to 
manifest disease compared to others. Thus, while it has been known for many years that 
plaque is the etiological factor, the role of factors contributing to an individual’s 
susceptibility is still not fully understood. Not all individuals with gingivitis will progress to 
periodontitis, and not all individuals with periodontitis will progress to tooth loss (Ohlrich 
et al., 2009). Therefore, periodontal diseases, including gingivitis, can be considered as a 
multifactorial condition influenced by the interaction between microbes and the host 
genome. Today, the role of external factors (e.g. microorganisms, smoking, stress etc.) is 
clearer than that of the genes. There are many scientific papers searching for the role of 
genes and their variants (polymorphisms) in the host response in aggressive and chronic 
periodontitis and their progression. In contrast, only a few studies examining the role of IL-
1, IL-6, IL-10, TNF- and MMP-9 genetic variability in gingivitis have been published to 
date. This review will analyze and summarize the literature on putative genetic risk factors 
predisposing to gingivitis. In addition, new data (still unpublished) on the role of 
interleukin-18 (IL-18) gene polymorphisms at positions -607C/A (rs1946518), -137G/C 
(rs187238) and -133C/G (rs360721) and their haplotypes in relation to gingivitis and 
microbial pathogens in Czech children are presented. 
2. Genetic predisposition to gingivitis 
For a detailed understanding of the interactions between bacteria and the inflammatory and 
immune responses of the individual, it is necessary to understand the pathogenesis of 
gingival disease. It is evident that an individual susceptibility to the presence of microbial 
pathogens plays an important role in the initiation and development of this disease.  
At the end of the last century, the existence of a phenomenon called “individual susceptibility“ 
was documented by many studies which proved familial aggregation of the disease and 
certain ethnic differences in the frequency of the occurrence of the individual forms of 
periodontal diseases. We assume that the genetic background of an individual plays a role 
in modulating susceptibility to a disease. Inheritance of susceptibility to periodontal disease 
varies enormously from nearly 100%  in “Mendelian forms of periodontitis“ to a minor rate 
of inheritance and a significant effect of external factors, as e.g. in plaque-induced gingivitis. 
Although the presence of some bacteria in plaque is a triggering factor, the organism 
response to this situation is significantly affected by the “genetic background“ of the 
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individual (Hassell  Harris, 1995, Michalowicz, 1994, Takashiba  Naruishi, 2006,  Yoshie 
et al., 2007, Laine et al., 2010). The phase of genetic analyses of the periodontal diseases 
started in the 1990s; it is usually referred to as the phase of looking for responsible – 
candidate – genes. Given the important role of inflammation and remodelling in periodontal 
tissues, the most frequently analyzed candidate genes are still the genes for selected 
receptors of the immune system, genes for proinflammatory cytokines, chemokines and 
growth factors, genes for matrix metalloproteinases and other enzymes. 
2.1 Methodological aspects of complex disease studies 
Research into the genetics of complex diseases represents one of the biggest challenges for 
scientists. From a methodological point of view, it is necessary to consider the 
etiopathogenetic character of complex diseases which differs from monogenic diseases in a 
number of aspects.  
The term complex diseases (traditionally referred to as multifactorially conditioned) indicate 
diseases, the origin and development of which is affected by a “complex“ of genetic and 
external factors. They do not exhibit classical Mendelian (dominant or recessive) inheritance 
as a result of a change in one locus (so-called diseases caused by one big reason). The genetic 
component of complex diseases also exhibits familial aggregation (i.e. non-random 
occurrence in families) but without an explicit type of transmission. Phenotype 
manifestation is a result of complex, often non-linear interactions, between the involved 
genes and also between the genes and external factors. Characteristic traits for complex 
diseases include: 1) incomplete penetration of a pathological phenotype pathological 
phenotype in some persons who inherited “unfavorable“ genotype does not manifest, 2) 
the existence of phenocopies the same phenotype can be present also in persons  who are 
not carriers of the given genotype, 3) genetic heterogeneity allelic – there can be more 
“pathogenic” mutations or polymorphisms in the individual genes, loci – clinical 
manifestation can develop as a consequence of changes in the genes at various loci, 4) 
polygenic inheritance predisposition to the disease increases only with the concurrence of a 
certain set of alleles, which if alone are not significantly pathogenic, 5) high population 
frequency of the alleles responsible for the development of the pathological phenotype, 6) 
co-operation of other mechanisms e.g. imprinting, mitochondrial inheritance, etc. (Lander 
& Schork, 1994).  
Therefore, study of these diseases present numerous problems that must be solved – besides 
already mentioned an unclear inheritance model, there is also an unknown number of the 
genes involved and an ambiguous definition of the clinical phenotype. The concrete 
disorder which is relevant in the context of the given disease and “closer“ to the genetic 
background than the resulting composed phenotype, is referred to as intermediary phenotype. 
There are principally two approaches for defining pathological phenotype (or disease) – the 
first approach is based on the alternative concept of health and disease (i.e. presence or absence 
of disease), the other approach corresponds to a so-called gradation model, disease and is 
perceived as a continuous function of a trait. In complex diseases it is rather a continuous 
transition of physiological values (phenotypes) to pathological ones. “Normality“of certain 
values and thus their implicitly presumed “unharmfulness“ is reflected by so-called 
reference intervals used in clinical medicine. However, use of statistical methods allows 
researchers to study the contribution of the genetic variability to the observed phenotype 
variability while applying both the approaches – alternative concept and continual model.  
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Genetic variability, means  that for the given gene more variants (i.e. alleles) with different 
frequency exist in population, counts for phenotype variability of traits. Based on 
population frequencies, these variants can be split into mutations and polymorphisms. The 
term mutation is usually used to indicate changes where frequency of a less frequent allele 
in population is lower than 1%. The term polymorphism conventionally indicates the 
existence of several (at least two) alleles; population frequency of the least frequent one is 
minimally 1%. The term genetic architecture of the given phenotype that characterizes how 
many genes and which of them participate in the genetic determination of a relevant 
disease, has not been determined for most of complex diseases. It is supposed that 
population frequency of a certain allele reflects its effect which can be either markedly 
pathogenic (in this case the relevant alleles are under selection pressure and are eliminated 
from the population – therefore they have a low population frequency) or in contrast low or 
neutral (alleles do not subject to selection and thus they are common in population). It has 
been assumed that these “neutral“ variants may be the basis for the genetic determination of 
common complex civilization diseases (a so-called common disease/common variant 
hypothesis). According to this hypothesis, the frequency of certain genetic variants 
determining the susceptibility to a certain trait (frequency of which could have been 
originally relatively low) increased over the time due to selection neutrality or a certain 
advantage in the given environment which has disappeared in the present (for example 
high blood pressure, hypercholesterolemia, etc.). On the contrary, an alternative, less 
probable hypothesis (a so-called common disease/rare variant hypothesis) assumes that 
common complex diseases, manifestation of which markedly depends on the environment, 
are common due to universal exposition to the environment and not because of sharing the 
same genetic variants.  
In complex diseases, the genetic background analysis is further complicated by the presence 
of interactions of the individual genetic variants (so-called “gene-gene interactions“) and 
their complex impact on the clinical manifestation. It is currently believed that these 
interactions can be described by a so-called multiplicative model which considers the 
existence of two (and more) risk loci while only a certain combination increases a risk of the 
given disease development. 
In addition, when studying complex diseases, external factors play an important role by 
significantly modifying an innate disposition of an individual to some disease and must be 
taken into consideration. Although there are no doubts about the role environmental factors 
play in the origin and development of complex diseases, finding the method for their exact 
definition and quantification still remains a challenge.  
2.2 Types of genetic studies 
If inheritance is confirmed to play a substantial role in the diseases with characteristics of a 
complex trait, the next step is mapping and identification of the genes involved. Therefore, 
genetics of complex diseases has to find answers for these principal questions: a) what genes 
participate in the development of the given disease, b) which variants play the most 
important role. A number of methods exist for localization and identification of the genes 
predisposing to complex diseases, each of them having some advantages and 
disadvantages. Methodologically there are two basic approaches: linkage or association 
studies; in which one or more candidate genes can be studied (a so-called “candidate gene 
approach“) or it is possible to work with the whole genome (a so-called “genome-wide 
approach“).  
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Both these approaches differ but principally; while the association approach compares the 
occurrence of a relevant genetic variant among phenotypically different persons (so-called 
“case-control“ studies), the genome-wide approach investigates transmission of the genetic 
and phenotypic trait  in affected families. Linkage studies can be further split into 
parametric and non-parametric (“allele sharing methods“), association studies are either 
retrospective, prospective or in a form of a “transmission disequilibrium test“, TDT.  
2.2.1 Linkage analysis  
Standard linkage analysis (so-called parametric) is a method effective for mapping 
monogenic diseases, but is rarely usable for study of complex diseases. For the linkage 
analysis it is necessary to know in advance (or estimate) the inheritance type and then to 
calculate recombinant and non-recombinant offspring. Then it is possible to: a) find out 
whether any genetic locus exists which recombines with a disease with frequency  lower 
than 50%, this is the frequency expected in the loci that are not in linkage and b) estimate the 
value , which gives the highest lod score (a so-called max). It means that this approach is 
based on the assumption of some inheritance type, which, when applied to the analysis of 
complex diseases (or traits), encounters a lot of problems. 
Methods of linkage analysis (i.e. non-parametric do not consider the model, do not work 
with the number of loci, external effects and probability of incomplete penetration) were 
developed. These methods are based only on the assumption that two affected relatives 
share the alleles predisposing to the disease origin. One of the variants of this method, the 
linkage analysis of affected sibpair, monitors equally affected, so-called concordant sibpairs 
(eliminating thus the decision whether the affected individual is a non-penetrant carrier of 
the alleles predisposing to the disease or whether he/she did not inherit these alleles) and 
the siblings are tested whether they inherited a certain section of the chromosome (marker) 
more frequently than it can be expected under random segregation. “Maximum likelihood 
odds ratio” is used to detect whether the allele-sharing deviates significantly from 50% 
(corresponding to chance), similarly as in the linkage analysis based on models, lod score is 
used to determine whether the decrease in recombination frequency below 50% is 
significant. The method of linkage analysis of the affected sibpairs is not burdened by 
possible false assumptions about the number of the loci involved and how the alleles in 
these loci interact. However, it is less sensitive and less accurate (Nussbaum et al., 2004). 
Another interesting method is the linkage analysis of highly discordant (differently affected) 
sibpairs. Similarly, this method does not require any assumption about the number of 
participating loci or the inheritance type. Presumably, these siblings will not share the same 
alleles at the loci involved in the given trait. DNA analysis is conducted using the 
polymorphic markers distributed along the whole genome. A decrease in the level of allele-
sharing detected in some marker indicates that the given marker is in linkage to the locus 
whose alleles participate in the studied physiological variable.  
2.2.2 Association analysis  
Association retrospective studies do not deal with the transmission of a complex trait in 
families, but compare allele frequency of a certain gene among the groups of affected and 
control (non-affected) unrelated persons. These studies analyze the alleles of genes whose 
products are pathophysiologically involved in the given disease (so-called candidate genes). 
If a certain allele of the given locus in the affected persons occurs in a higher frequency than 
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in controls, then the association with a disease is considered. The strength of association is 
expressed as “odds ratio“ calculated from the frequency of the relevant allele in patients and 
controls (OR=ad/bc, where a = number of patients with the given allele, c = number of 
controls with the given allele, b = number of patients without the given allele and d = 
number of controls without the given allele). If the frequency of the studied allele in patients 
is in accordance with that in controls the odds ratio equals 1. Direct association studies deal 
with concrete substitutions in which a direct, causal effect on a phenotype is presumed. On 
the contrary, so-called indirect association studies are based on the assumption that the 
alleles in the vicinity of the causal allele segregate jointly (in a so-called haplotype block) 
and markers in the area are in complete linkage disequilibrium (LD) with causal 
substitution. It means that the vicinity of the variant is more important than the effect of the 
substitution itself. 
These association methods are an important tool for seeking the genes involved in the origin 
of complex diseases and are also used for the analysis of genetic determination of gingivitis. 
Their advantage is that they can quite easily be conducted (we need only samples from 
groups of affected individuals and controls). There is no need to work out any laborious 
pedigree studies and collect samples from relatives. On the other hand, the results obtained 
must be carefully interpreted because an increase in likelihood ratio for some allele of a 
certain locus is not evidence that this allele or the whole locus are actually involved in the 
disease pathogenesis. Firstly, the studied allele can be in linkage disequilibrium with 
another allele, which really participates in the pathogenesis of the given disease (as 
explained above). Second, more serious limitation of the association studies is their 
sensitivity to the consequences of population stratification. If the population is split into 
several subpopulations (e.g. based on nationalities) and unions between members of 
different subpopulations are only rare, it can happen that the disease occurring more 
frequently in one of the subgroups will be falsely associated with some of the alleles that are 
more frequent in this subpopulation than in the population as a whole. The origin of these 
“false“ associations can be minimized, but not fully eliminated, by a careful selection of the 
controls. 
Prospective association study is based on the defined population sample (cohort), with the 
determined presence of the studied risk factor, the development of the relevant disease (or 
detected phenotype) is monitored over a given time horizon. Subsequently, frequencies of 
alleles (or genotypes, haplotypes, etc.) are compared among symptomless individuals and 
patients with disease. The advantage of this approach is that it is not necessary to make 
selection from the control group; the main disadvantage being time and financial costs. 
Transmission disequilibrium test, TDT is based on the analysis of genotypes of the affected 
persons (probands) and their parents who are heterozygotes for the studied 
polymorphisms (at least one parent must fulfill this condition). The method tests whether 
the allele of a certain genetic marker from the heterozygous parent is transmitted to the 
affected offspring so frequently as it could be expected under random Mendelian 
segregation (when each parental allele is transmitted with the likelihood of 50 %). 
Transmission with a higher frequency indicates an association of the relevant allele with 
the given disease. The advantage of this method is the fact that it does not require the 
analysis of siblings (affected or non-affected by the disease) and that it is not influenced 
by population stratification. 
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2.2.3 Study of haplotypes 
The term haplotype denotes a combination of alleles of the individual polymorphisms and 
mutations in the gene, or a longer chromosome segment, or a particular nucleotide sequence 
of one of the pairs of homologous chromosomes that is inherited as a whole. While studying 
the candidate genes in association studies, attention has been devoted to a haplotype 
analysis. It is due to the fact that protein production encoded by a relevant candidate gene is 
a result of summary effects of all variants in the given gene which can affect transcription 
(or splicing, translation, RNA stability, posttranslational modifications, etc.) and which are 
difficult to reveal by the analysis of the individual variants. In addition, it has been 
suggested that genetic variability in a population is unambiguously structured in 
haplotypes; the haplotype analysis thus reduces the numbers of the analyzed variants, 
which are not mutually independent, increasing thus statistical power of the test. 
A variety of methods exist for haplotype detection but none of them is quite trivial. In 
linkage studies, haplotypes can be derived if maternal and paternal genotypes are known, 
suitable programs are for example: GENEHUNTER (Nyholt, 2002), Simwalk2 (Sobel  
Lange, 1996) or Merlin (Abecasis et al., 2002). In other cases, haplotypes can be either 
derived statistically or established through molecular haplotyping. The method for the 
haplotype inference from genotype data is used most frequently, namely in large association 
studies. Available statistical programs are based on some of three algorithms: (a) maximum 
likelihood SNPHAP, THESIAS (Tregouet et al., 2004), PLEM (Qin et al., 2002), (b) 
parsimons e.g. HAINFREX (Clark et al., 1998) or (c) Bayesian HAPLOTYPER (Niu et al., 
2002), PHASE (Stephens et al., 2001, Stephens  Donnelly, 2003). Besides the algorithm 
itself, these programs differ in a number of other parameters and initial presumptions such 
as set size, requirements for maintenance of Hardy-Weinberg equilibrium, requirements for 
completeness of genotype data, etc. A number of surveys and comparisons of available 
software packages have been published (Niu, 2004, Salem et al., 2005).  
2.2.4 ”High-capacity” techniques 
High-capacity “high-throughput“ methods have been intensively developed for a rapid and  
simultaneous assay of a large number of markers in the scope of the whole genome or its 
part in vast sets. Other interesting approaches are, for example, “multiplexing“ (for a 
parallel detection of a large number of markers – e.g. SNPs in one reaction) or “DNA 
pooling“ (using mixed DNA samples collected from hundreds to thousands of individuals 
in which allele frequencies are determined). The high-capacity techniques often use the 
methods of DNA microarrays and techniques based on PCR and their modifications (Shi, 
2002, Tsuchihashi  Dracopolli, 2002, Liu B et al., 2004, Brenan et al., 2009).  
2.3 Interpretation of results from genetic studies 
The aim of genetic research into complex, multifactorially conditioned diseases, such as 
gingivitis, is to find, by means of proof of positive linkage or association of a particular 
parameter with the disease, risk or protective variants increasing or on the contrary 
decreasing the susceptibility to the origin or development of the studied disease. However, 
the issue of establishing the causality of any relationship found is more complicated none of 
the methods given above is able to confirm it directly. 
Today association studies are preferred for the analysis of complex diseases (despite the 
disadvantage mentioned above with the problematic selection of the control group). This is 
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given by the character of these diseases (first of all polygenic type of inheritance, 
participation of the alleles with predominantly “smaller” effect, late clinical manifestation 
that restricts the availability of the analysis of affected relatives) and mainly by an important 
role of the external environment which can be studied with linkage studies only with 
difficulties. 
Facts about etiopathogenesis of multifactorially conditioned diseases, noted above, suggest 
that genetic predisposition to gingivitis is affected by a number of loci that may interact with 
each other in a complex fashion. It means that the genetic variant if studied separately is not 
necessarily associated with the given phenotype or given disease. This may be the reason 
why a number of inconsistent results of SNPs analyses from different studies exist. There is 
a clear trend towards more complex–haplotype or whole-genome studies that can analyze 
simultaneously thousands to tens of thousands of markers for the given phenotype. This 
strategy evades one of the disadvantages of candidate-gene association studies as it does not 
work with an assumption of relevant gene-disease association. On the other hand, it is 
necessary to analyze a large number of gene variants in sets containing relatively few 
individuals, which leads to an increased probability of false positive results. The methods 
commonly used for multiple comparisons correction (e.g. Bonferroni correction, Holm’s 
method, etc.) are more conservative in the situation where high LD between variables are 
present. 
Although as mentioned above molecular-genetic methods which are able to analyze rapidly 
a huge number of markers are available, “ideal“ statistical programs for the evaluation of 
the acquired data are still missing (eg. how to minimize the likelihood of false positive 
results at a high number of the analyzed variants in a small number of persons, evaluation 
of interaction effects between the particular genes and gene variants and environment). Of 
more recent methods, so-called multilocus methods can be mentioned (Hoh et al., 2001, Hoh 
 Ott, 2003). They have been used for a relatively short time and it is too early to evaluate 
them. 
3. Strategy of the recovery of published data 
A comprehensive literature search on the PubMed database up to January 2011 was 
conducted using the keyword gingivitis in combination with the words gene mutation or 
polymorphism. The studies selected for the review (a) were written in English, (b) had a 
case-control design including patients with gingivitis (G), and (c) reported genotype 
distribution. 
In the present review, the most common variant of the polymorphic locus is nominated as a 
normal (N) variant (allele). The less frequent allele is designed as a rare (R) variant (allele). 
Table 1 gives the frequencies of the carriage rate of the R-alleles (frequency of N/R and RR 
genotypes) among patients and controls. In addition, we showed in this table whether or not 
the authors of the cited papers have reported statistically significant differences between 
cases and controls. 
4. Candidate genes in relation to gingivitis  
Considering the significant role of inflammation in gingivitis, of all the candidate genes, 
mainly the proinflammatory (IL-1, IL-6, TNF- and LT-) and antiinflammatory (IL-10) 
cytokine genes and genes for matrix metalloproteinases (MMP-9) have been analyzed (Table 
www.intechopen.com
 
Gene Polymorphisms in Gingivitis 
 
217 
1). This review presents all studies investigating association of genetic polymorphisms in 
relation to plaque-induced gingivitis in the “case-control study“ design. 
 
Ethnicity 
of subjects 
Gene SNP Controls 
Patients with 
gingivitis 
Associated 
with  
gingivitis 
Reference 
   n 
R-allele 
carriage
n 
R-allele 
carriage
Caucasian 
IL-1 +3953C/T
45 
27% 
20 
45% - Galbraith 
et al., 1999 TNF- -308G/A 24% 35% - 
Caucasian IL-10 -1082G/A 86 59% 174 75% +1 
Dashash et 
al., 2005 
Caucasian IL-10 
-1082G/A
 
84 
64% 
 
164 
77% - (+2) 
Dashash et 
al., 2006 
-819C/T 39% 43% - (+2) 
-592C/A 39% 43% - (+2) 
Caucasian IL-1RN 86 repeat 48 35% 98 43% +3 
Dashash et 
al., 2007 
Caucasian 
IL-6 -174G/C 
 
183 
61% 
 
272 
68% +4 Izakovico-
va Holla et 
al., 2008 
 -572G/C 11% 12% - (+5) 
 -597A/G 64% 66% - (+5) 
Caucasian 
IL-18 -607A/C 
151 
62% 
147 
64% - Vokurka et 
al., 2009 MMP-9 -1562C/T 17% 29% +6 
- = association not found, + = association found 
+1An association with gingivitis was found for R-allele carriage  
- (+2) Genotype GCC/GCC (-1082/-819/-592) was protective against gingivitis 
-3 R-allele (IL-1 RN*2) was protective against gingivitis, even after correction for plaque  
+4 An association with gingivitis was found for R-allele carriage and R/R genotype carriage even after 
correction for plaque levels 
- (+5) Haplotype C(-174)/G(-572)/A(-597) was associated with gingivitis 
+6An association with gingivitis was found for MMP-8 R-allele carriage (mainly in boys) and for 
combined genotype: carriage of MMP-9 C/T and IL-18 C/C genotypes 
Table 1. Gene polymorphisms and carriage rate of the rare (R) – allele in case-control studies 
and association with susceptibility to gingivitis 
4.1 Polymorphisms in the IL-1 gene cluster 
Interleukin-1, one of the main proinflammatory cytokines, is an important mediator of the 
immune response. IL-1 production may be induced by a number of stimuli, including 
products of microorganisms or proinflammatory mediators produced by cells during the 
immune response. Pleiotropic effects of this interleukin include activation of the endothelial 
cells, which helps migration of neutrophils and monocytes/macrophages to an 
inflammatory site, proliferation of fibroblasts, activation of osteoclasts and release of 
enzymes participating in intercellular substance destruction, so-called matrix 
metalloproteinases. The role of IL-1 in periodontal disease pathogenesis has been confirmed 
both in animal models (Assuma et al., 1998) and in human medicine; the increased levels of 
this interleukin are found in tissues and sulcular fluid in patients with gingivitis or 
periodontitis (Ishihara et al., 1997, Rawlinson et al., 2000).  
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The genes encoding for IL-1 and IL-1 (proinflammatory) and IL-1/IL-1-receptor 
antagonist (IL-1RN, antiinflammatory) cytokine are assigned to chromosome 2q13-21. In all 
three genes several polymorphic loci have been described. Based on the number of 
published reports, the two single nucleotide polymorphisms (SNPs) connected with 
cytosine - thymine interchange (C/T), one within the promoter region of the gene for IL-1 
(at position -889) and the other  within the fifth exon of the IL-1  gene (at position +3953), 
appear to be the most studied genetic variant in periodontal diseases. The IL-1 -889 and IL-
1 +3953 R-alleles have been shown to increase and the IL-1RN VNTR (a variable number of 
86-bp tandem repeat in the second intron) R-alleles, to decrease gene transcription or the 
protein production levels (Shiroddria et al., 2000, Pociot et al., 1992, Andus et al., 1997) 
resulting in the R-allele carriers in a more pronounced IL-1 proinflammatory response 
(Laine et al., 2010). 
Results of two case-control studies of IL-1 genes in patients with gingivitis are presented in 
Table 1. The SNP IL-1 +3954 (+3953) was firstly analyzed as a risk factor for gingivitis 
(Galbraith et al., 1999). Groups of twenty patients with gingivitis and 20 controls of 
unknown periodontal health status were compared and no differences in IL-1 +3954 allele or 
genotype frequencies were found. In contrast, a significant association of this variant with 
advanced adult periodontitis was confirmed (Galbraith et al., 1999). However, more recent 
studies have reported a significant association between IL-1RN gene polymorphism and 
gingivitis in 146 Caucasian children (Dashash et al., 2007). The IL-1 RN*2 allele (A2) was 
protective against the development of gingivitis. The same allele has been previously 
associated with an increased production of IL-1 RN (Hurme and Santtila, 1998) and a 
protective role against rheumatoid arthritis (Lee et al., 2004). Moreover, studies of IL-1 
antagonists on periodontitis in animal models have shown that IL-1 Ra is able to inhibit the 
osteoclast-like cell formation mediated by A. actinomycetemcomitans Y4 capsular 
polysaccharide in mouse marrow cultures and also to inhibit the differentiation of 
osteoclasts induced by IL-1 (Nishihara et al., 1995).Taken altogether, the IL-1 gene cluster 
polymorphisms cannot be considered as general risk factors for gingivitis susceptibility. A 
very low number of case-control studies have been published so far. The decision whether 
and how the above given variants can modulate (increase or decrease) risk of gingivitis 
development will require other studies to be performed and be subject to a meta-analysis.  
Another question is the effect of genetic variability on gingival inflammatory parameters. 
Lang and colleagues (2000) conducted a prospective longitudinal study that investigated the 
association between the IL-1 complex (IL-1 -889C/T and IL-1+3954C/T) genotype and 
gingival inflammation assessed using the bleeding on probing (BOP). The results for 139 
non-smoking subjects indicated that IL-1 positive genotype patients were found to have a 
significantly higher chance of presenting BOP and twice as likely to  have increased BOP 
over a four-appointment recall (Shapira et al., 2005). Using the experimental gingivitis 
model, Jepsen et al. (2003) investigated the relationship of IL-1 genotype and the 
susceptibility to develop gingivitis in 10-positive and 10-negative volunteers with healthy 
gingiva. They did not find any association between parameters of gingival inflammation 
(such as BOP) and IL-1 genotype after 21 days of no plaque control. Also Goodson and 
colleagues (2000) found significant differences in BOP between similar groups of subjects (7 
IL-1 positive vs. 13 IL-1 negative) in a 10-day experimental gingivitis trial. In contrast, 
Scapoli et al. (2005) did not find any significant association between IL-1 +4845 (-889), IL-
1 (-3953) or combined genotype of both variants and the clinical parameters in the 
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experimental gingivitis trial in the overall population (N=96) of high and low responder. 
However, genotype distributions of IL-1RN and IL-1 -511 variants were statistically 
significantly different between both groups. Müller and Nusair (2007, 2010) described the 
effect of combined alleles 2 (R-alleles) of both IL-1 -889 and IL-1 +3954 on lower gingival 
bleeding tendency in plaque-induced gingivitis in a group of fifty subjects of 19-28 years of 
age. The present studies suggested a subtle influence of the IL-1 gene cluster 
polymorphisms on gingival inflammation. However, further well-designed larger studies 
are necessary to confirm these preliminary findings and the role of IL-1 variants in gingivitis 
susceptibility. 
4.2 Polymorphisms in the IL-6 gene 
Interleukin-6 is a pleiotropic cytokine produced by a variety of cells, such as gingival 
fibroblasts, endothelial cells, monocytes and T lymphocytes. It regulates differentiation 
and/or activation of macrophages and T cells, growth and differentiation of B cells and 
production of antibodies (Papanicolaou et al., 1998). IL-6 is known to stimulate protein 
production by hepatocytes during the acute phase of a systemic inflammation. IL-6 
expression under the normal conditions is minute. However, it is significantly stimulated by 
proinflammatory products, such as endotoxin (LPS). Besides affecting inflammation, IL-6 
activates osteoclasts thus disturbing the balance between bone formation and degradation 
(Ota et al., 1999). On the other hand, it can also induce production of the IL-1 antagonist 
receptor and soluble receptor for TNF- and thus block effects of these proinflammatory 
mediators, which suggest possible IL-6 anti-inflammatory effects (Tilg et al., 1994). 
The IL-6 gene is localized on chromosome 7 (7p21, Bawcock et al., 1988). The IL-6 5´-region 
contains numerous polymorphisms that directly influence the expression of the protein. The 
most frequently studied variants are three single-nucleotide variants (SNPs) at positions -
174G/C, -572G/C and -597G/A together with AnTn  polymorphism (Osiri et al., 1999, Terry 
et al., 2000). The first studies dealing with the “functionality“of the given variants 
underlined an important role of -174G/C polymorphism that involves a binding site for the 
transcription factor NF-IL-6 the presence of the C allele of this polymorphism leads to a 
lower basal and by lipopolysaccharide and IL-1 stimulated expression and reduction in 
plasma IL-6 levels compared to the common G allele (Ferrari et al., 2003). More recently, it 
has been shown that a number of other promoter polymorphisms, and mainly their mutual 
interactions, can significantly affect the expression of these genes (Müller-Steinhardt et al. 
2007).  
There is only one case-control study on the role of IL-6 polymorphisms in gingivitis (Table 
1). Data on the relationship of 3 promoter polymorphisms in the IL-6 gene for the 
development of gingivitis was summarized in our previous study (Izakovicova Holla et al., 
2008). The study included 455 children aged 11-13 years. Plaque-induced gingivitis was 
diagnosed in 272 of them and 183 children were healthy. Differences in allele frequencies or 
genotype distributions were not statistically significant for IL-6 -572G/C and -597G/A 
polymorphisms. However, frequency of IL-6 -174 R-allele was significantly higher in 
children with gingivitis and this allele was associated with gingivitis regardless of the 
amount of plaque. Boys who carried -174 C allele with the simultaneous presence of plaque 
were at the highest risk for the gingivitis development. Haplotype analysis proved a 
significant difference in haplotype frequencies between the healthy and diseased children, 
risks for the gingivitis development were nearly 1.5-times higher in children with  CGA (-
174C/-572G/-597A) haplotype and on the contrary reduced in children with  GGG variant. 
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However, Scapoli et al. (2007) did not find any significant association between -174G/C and 
-597G/A variants and the clinical parameters in the experimental gingivitis trial in the 
overall population (N=96) of high and low responder. In addition, genotype distributions of 
both IL-6 polymorphisms did not differ between both groups statistically significantly. 
We concluded that the IL-6 polymorphisms may be associated with plaque-induced 
gingivitis susceptibility, similarly as with CP susceptibility (Laine et al., 2010). However, 
other studies and meta-analysis are needed before the final conclusion is made. 
4.3 Polymorphisms in the IL-10 gene 
Interleukin-10 (IL-10) is an antiinflammatory cytokine synthesized by activated monocytes 
and T-lymphocytes in response to inflammation (Kobayashi et al., 2011). It inhibits 
production of several cytokines such as IL-1α, IL-1, IL-6, TNF-α, and IL-10 itself. IL-10 
production is partially genetically determined (Westendorp et al., 1997). The gene encoding 
for IL-10 is located on chromosome 1q31-q32, in a cluster with other interleukin genes, such 
as IL-19, IL-20 and IL-24. Several polymorphic sites in the IL-10 promoter region have been 
identified at positions -1082, -819, -627, -592, and -590. SNP at position -1082 lies within a 
putative Ets transcription factor binding site (Kube et al., 1995), variant at position -819 may 
affect an estrogen responsive element (Scarel-Caminaga et al., 2004) and polymorphism at -
592 can have a negative regulatory function (Kube et al., 1995). The IL-10 -1082G/A, -
819C/T and -592C/A variants showed strong linkage disequilibrium and form two common 
haplotypes. The R-allele of the -592 polymorphism has been associated with decreased 
synthesis of IL-10 in vivo and in vitro (Koss et al., 2000, Crawley et al., 1999). IL-10 plays a 
protective role in periodontal destruction due to inhibition of matrix metalloproteinases 
(MMPs) and receptor activator for nuclear factor-B (RANK) system. Therefore, the 
individuals with decreased production of IL-10 can be less protected against bacterial 
pathogens.  
In Table 1, results from two published studies investigating IL-10 gene polymorphisms in 
gingivitis susceptibility are presented. Dashash and colleagues in the first study (2005) 
analyzed the relationship between IL-10 -1082G/A variant and susceptibility to gingivitis 
among 260 Caucasian children (86 controls and 174 patients), aged 8 to 12 years from the 
UK. An increased risk of having gingivitis was found in allele A positive children, 
regardless of plaque or age. This allele was previously associated with low production of 
this cytokine (Turner et al., 1997). One year later, the same authors published haplotype 
analysis of three IL-10 gene variants at positions -1082, -819 and -592 in the same group of 
subjects and found that GCC haplotype was protective and ACC and ATA haplotypes were 
associated with gingivitis manifestation.  
In conclusion, IL-10 alleles, genotypes and haplotypes have been associated with gingivitis 
susceptibility. However, both studies were published by the same authors using the same 
subjects and the results have not yet been replicated in another population. Therefore, the 
IL-10 gene may be one of the “candidate“ genes for gingivitis but these positive associations 
must be confirmed in other  ethnic groups. 
4.4 Polymorphisms in the TNF genes 
Tumor necrosis factor  (TNF-) and tumor necrosis factor  (TNF-, newly lymphotoxin  - 
LT-) are key pleiotrophic proinflammatory cytokines. TNF- is released primarily by 
monocytes and macrophages and triggers a cascade of other mediators of inflammation 
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(Beutler & Grau, 1993). LT- which plays an important role in tumor cell destruction and 
viral infections is released mainly by T-lymphocytes. 
Besides its local para- , juxta- and autocrine effects within the proinflammatory activities, 
TNF- stimulates expression of some enzymes important in the remodelling of extracellular 
matrix;  so-called matrix metalloproteinases - e.g. MMP-1, MMP-8 and MMP-13 (Panagakos 
 Kumar, 1995 Johansson et al., 1997) participating in degradation of periodontal ligaments 
(Birkedal-Hansen H, 1993). A great number of studies have found elevated levels of these 
cytokines in sulcular fluid and higher expression of TNF- in the inflamed periodontal 
tissues in patients (Roberts et al., 1997). Besides the effects on the soft tissues of the 
periodontium, TNF- is one of key cytokines that promotes bone resorption. 
The genes for TNF- and LT- lie in the MHC class III region on the long arm of  
chromosome 6 (6p.21) between  HLA-B and DR (Carroll et al., 1987). Many polymorphisms 
have been found in the TNF gene cluster, the G/A variant at position –308 in the promoter 
region of the TNF- gene being the most profoundly studied. The less frequent allele of this 
polymorphism (-308A, R-allele) has been associated with increased production of TNF in 
vitro (Braun et al., 1996) and an increased risk of developing many diseases, including 
periodontitis (Galbraith et al., 1999). Only one study about the role of TNF- polymorphism 
in gingivitis has been published so far (Table 1).  
Galbraith and colleagues (1999) studied 20 subjects with plaque-associated gingivitis and 20 
patients with adult periodontitis aged 35 and 65 years. Referent population consisted of 45 
unrelated Caucasian subjects of unknown periodontal health status. For the TNF- -308 
variant, the frequencies of the R-allele were comparable between the reference subjects and 
patients with gingivitis and varied between 22.5-26.7%. The second, but not case-control 
study was afterwards published by Scapoli et al. (2007) on the group of 96 systemically and 
periodontally healthy individuals as a 21-day experimental gingivitis clinical trial. No 
relationship between the TNF- -308 or LT- +252 polymorphism and susceptibility to 
gingivitis was demonstrated. 
To date there are very limited data analyzing possible effects of TNF gene variants in 
plaque-induced gingivitis; none, so far, has proven an association of the TNF gene(s) with 
this disease.  
4.5 Polymorphisms in the MMP-9 gene 
Enzymes denoted as matrix metalloproteinases (MMPs) are important mediators of tissue 
destruction in periodontal disease. Matrix metalloproteinases are secreted by various cells - 
polymorphonuclear leukocytes, macrophages, fibroblasts, epithelial and endothelial cells. 
(Birkedal-Hansen H, 1993). MMPs expression and activity are regulated by different 
mechanisms, including modulation of transcription, activation of latent pro-forms and 
inhibition by tissue inhibitors of metalloproteinases – TIMPs (Brew et al., 2000).  
MMP-9 (also known as gelatinase B or 92-kDa type IV collagenase) is one of the MMPs 
active against denaturated collagen (gelatin) and collagen types IV, V and XI together with 
proteoglycans and elastin. The coding gene is located on chromosome 20q11.2-13.1 and 
several polymorphisms have been detected in the MMP-9 gene, some of them have been 
found to be “functional” (Zhang et al., 1999). The C to T substitution in position -1562 
increases transcriptional activity of the MMP-9 in macrophages, as confirmed by in vitro 
studies (Zhang et al., 1999). In agreement with these findings from the in vitro experiments it 
was found that persons carrying the T allele have increased MMP-9 levels in plasma (Zhang 
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et al., 1999). Higher levels of the MMP-9 in patients with periodontitits in comparison to the 
healthy population were also observed (Ingman et al., 1996). However, in later studies no 
associations of MMP-9 functional polymorphisms with plasma MMP-9 levels in healthy 
were found (Demacq et al., 2008). No correlation between MMP-9 -1562C/T variant and 
salivary MMP-9 levels was found. However, significantly higher levels of MMP-9 were 
detected in patients with CP and correlated with clinical parameters of periodontal 
destruction (Isaza-Guzman et al., 2011). 
Data on frequencies of polymorphism in the gene for MMP-9 (-1562C/T) together with 
polymorphism in the gene for IL-18 (–607A/C) in children with gingivitis have been 
published only in one study so far (Table 1). In the association case-control study in Czech 
adolescents aged 11-13 years, the authors demonstrated differences in frequencies of MMP-9 
–1562C/T polymorphism between children with healthy gingiva and those with plaque-
induced gingivitis. Boys with gingivitis carried the T allele (and genotypes with this allele) 
significantly more frequently compared to children with healthy gingiva (15.9% vs. 6.5%). 
Patients with combined genotype CT (of MMP-9 -1562C/T) and CC (of IL18 -607A/C) had 
5.6 times higher risk of the gingivitis development compared to persons without this 
genotype (Vokurka et al., 2009). 
Although the matrix metalloproteinase genes seem good candidates for their association 
with periodontal inflammation and destruction, investigations have not yet yielded 
sufficient data for conclusions about the role of these genes in plaque-induced gingivitis. 
5. Interleukin-18 (IL-18) gene polymorphism in relation to gingivitis and 
microbial pathogens in Czech population 
5.1 Introduction 
Interleukin-18 (IL-18) belongs to possible factors that can play a role in the development of 
periodontal disease. It is a pro-inflammatory cytokine, a member of the IL-1 family that was 
originally described as INF- inducing factor that modulates both innate and adaptive 
immunity (Okamura et al., 1995). It is generally considered to be involved in the T-helper 
type 1 (Th1)-mediated immune response. IL-18 directly increases the production of TNF- 
and subsequent release of IL-1 and IL-8 from monocytes. On the other hand, IL-18 might 
initiate Th2 responses with production of IgE via the stimulation of IL-4 and IL-13 synthesis 
in mast cells and basophils and eosinophil recruitment. The local production of IL-1 and 
IL-18 in the gingival tissue samples (Johnson & Serio, 2005) or gingival crevicular fluid 
(Orozco et al., 2006) increases with increasing inflammation and IL-18 was the predominant 
cytokine at both gingivitis and periodontitis sites. Among other functions, regulation of 
expression of MMPs and stimulation of MMP-9 active form can be mentioned (Delaleu et al., 
2004).  
The gene for human IL-18 is located at chromosome 11q22.2-22.3. It is composed of 6 exons 
(Kalina et al., 2000) and several polymorphisms have been identified in the IL-18 gene 
(Zhang et al., 1999). Among them, -607A/C (rs1946518), -137C/G (rs187238) in promoter 
and -133C/G (rs4988359) in intron 1 have been studied in more detail with respect to 
transcriptional activity or IL-18 production by monocytes (Liang et al., 2008; Arimitsu et al., 
2006). A change from C to A at position -607 disrupts a potential binding site for cAMP-
responsive element binding protein, while allele C at -137C/G has been shown 
experimentally to disrupt a confirmed H4TF1-binding site (Giedraitis et al., 2001). The -
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133C/G SNP in intron 1 is situated in an NF-1 binding site that is supposed to activate the 
transcription of a number of immune proteins, such as transforming growth factor (TGF)-1, 
tumor necrosis factor (TNF) receptor 2, and IL-1 (Krohn et al., 1999).  
There are only three studies of the IL-18 gene polymorphisms in chronic periodontitis 
(Folwaczny et al., 2005, Noack et al., 2008, 2009). Only one previous study on the potential 
association between IL-18 -607A/C variant and risk of gingivitis has been published so far 
by our group (Vokurka et al., 2009). With respect to the key role of interleukins in 
inflammatory response in gingivitis, the IL-18 gene is an obvious functional candidate for 
this disease. We analyzed the distributions of the IL-18 -607A/C, -137C/G and -133 C/G 
alleles, genotypes, and haplotypes in Czech children aged 11 to 13 years with plaque-
induced gingivitis and with healthy gingiva. 
5.2 Materials and methods 
5.2.1 Subjects 
A total of 572 Caucasian adolescents (311 boys and 261 girls) of exclusively Czech 
nationality, aged 11-13 years, selected from the ELSPAC (European Longitudinal Study of 
Pregnancy and Childhood) Brno group, which comprises over 5000 children and their 
families, was examined to assess gingival health in this case-control study. Children 
underwent a dental examination at the Clinic of Stomatology, St. Anne´s University 
Hospital and Faculty of Medicine, Masaryk University. Inclusion criteria consisted of a 
simple informed consent of the respective children and their families and of their 
willingness to participate. Thus, the randomness of the set is ensured; although a slight drift 
towards families with mothers with higher education can be expected. The study group 
comprised children with clinical evidence of plaque induced gingivitis (N=307, 197 boys and 
110 girls). The healthy group (N=265, 114 boys and 151 girls) included children who had 
healthy gingiva with no clinical signs of inflammation (GI index = 0). 
The clinical assessment was carried out by one investigator and the following parameters 
were assessed: DMFT (decayed/missing/filled teeth) score, gingival index (GI), plaque 
index (PI) and calculus index (CSI) as previously described (Izakovicova Holla et al., 2008). 
The radiograph examination was not performed as it was not part of routine care for these 
adolescents and would therefore have been deemed unethical. Phenotype status was 
assigned without knowledge of genotype by independent investigators. 
The study was performed with the approval of the Committee for Ethics of the Medical 
Faculty, Masaryk University Brno and written informed consent was obtained from all 
parents (in case of children), in line with the Helsinki declaration before inclusion in the 
study. 
5.2.2 Molecular assessment of periodontopathic bacteria  
Microbial samples were taken from the subgroups of randomly selected subjects (N=207). 
Microbial samples were collected from gingival sulcus of each quadrant by inserting a 
sterile paper point into a base of the pocket for 20 seconds. Bacterial plaque samples from 
each individual were pooled in one tube. The detection of periodontal bacteria was 
performed using a commercially available microarray system (ParoCheck®; Greiner Bio-
One GmbH, Frickenhausen, Germany), which allows the simultaneous detection of up to 20 
different oral bacterial species based on species-specific highly conserved regions from the 
16S rRNA gene. The ParoCheck® chip is a coated glass slide with a total of 86 DNA 
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measuring points, which can be evaluated by all commercially available microarray 
scanners. In this study, dental paper points soaked with gingival fluid were shaken out into 
deionized water and 1 μl aliquot was put in  a 20- μl reaction mixture containing 0.2 μl Taq 
DNA polymerase and 18.8 μl Master Mix supplied with the Parocheck® kit (containing 
buffers, MgCl2, dNTPs, DNase-free water and fluorophore-labelled primers). PCR was 
performed to amplify the target sequences and the cycling conditions used were as follows: 
94oC for 1 min followed by 45 cycles at 95oC for 20 s, annealing at 60oC for 20 s, 72oC for 30 s 
and final elongation at 72oC for 1 min. Next, the labelled amplified products were 
hybridized to pathogen-specific oligomers according to the manufacturer’s instructions. 
This step was first performed at 60oC in a steam-saturated atmosphere for 5 min. Next, 30 μl 
hybridization buffer was mixed with 5 μl PCR product at room temperature and incubated 
for 2 min at 95oC using a heating block. Then, 25 μl hybridization mix was transferred into 
each well of the chip and incubated for 10 min at 60oC. After washing and then drying using 
an air spray, the chip was read using a scanner (Axon 4100 A; Axon Instruments Inc., Union 
City, CA) and the software Paroreport 20. The bacterial counts were semi-quantitatively 
analyzed on a graduated scale ranging from 0 to 4 according to the dot intensity measured 
and were calibrated to serial dilutions of the relevant microorganisms. 
5.2.3 Genotyping 
Genomic DNA was extracted from peripheral blood leukocytes by a standard method using 
the proteinase K digestion of cells. For detection of single nucleotide polymorphisms (SNP) 
in promoter at positions -607C/A and -137C/G allele-specific PCR according to Giedraitis et 
al. (Giedraitis et al., 2001) was slightly adopted. The original PCR-RFLP method according 
to Kruse et al. (Kruse et al., 2003) was used for the analysis of SNP in intron 1 at position 
-133C/G). The PCR products were then digested by the restriction enzyme SmaI. The 
primers, PCR conditions, and restriction enzymes used are listed in Table 2. The genotyping 
was performed by one investigator unaware of the phenotype. 10% subjects were genotyped 
twice for each polymorphism to verify correctness of the analysis. 
 
 
 
SNP  
 
Primers Annealing 
temperature 
Enzyme 
-607A/C 
(rs1946518) 
5´-TAACCTCATTCAGGACTTCC- 3´;  
5´-CTTTGCTATCATTCCAGGAA- 3´; 
5´-GTTGCAGAAAGTGTAAAAATTATTAA-3´;  
5´- GTTGCAGAAAGTGTAAAAATTATAC- 3´ 
64°C, 57°C      - 
-137C/G 
(rs187238) 
5´-AGGAGGGCAAAATGCACTGG-3´; 
5´- CCAATAGGACTGATTA-3´ 
5´-CCCCAACTTTTACGGAAGAAAAG-3´; 
5´CCCCAACTTTTACGGAAGAAAAC-3´ 
68°C, 62°C      - 
 
-133C/G 
(rs4988359) 
5´-GTATTCATAAGCTGAAACTCCCCG-3´; 
5´-TGTTCTATGGCATTAGCCTTAC-3´ 
53°C SmaI 
 
 
Table 2. PCR-RFLP analysis  
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5.2.4 Statistical analyses 
Comparisons were made between allelic and genotype frequencies in the cases and controls. 
The allele frequencies were calculated from the observed numbers of genotypes. The 
significance of differences in the allele frequencies among groups was determined by 
Fischer’s exact test. χ2 analysis was used to test for deviation of genotype distribution from 
Hardy-Weinberg equilibrium and for comparison of differences in genotype combinations 
among groups. Variations in the quantity of subgingival bacteria corresponding to the 
particular genotypes were tested by Kruskal-Wallis ANOVA and/or Fisher´s exact test. 
Only the values of P less than 0.05 were considered significant. To examine the LD between 
all SNPs, pairwise LD coefficients D´ and haplotype frequencies were calculated using the 
SNPAnalyzer program (http://snp.istech.info/istech/board/login_form.jsp). Contingency 
table analysis, odds ratio (OR), 95% confidence intervals and significance values were 
estimated with the use of the Statistica ver. 9.0 (Statsoft Inc., Tulsa, Oklahoma, USA) 
program package.  
5.2.5 Results  
The genotype and allele frequencies of the IL-18 gene polymorphisms in healthy children 
and those with gingivitis are presented in Table 3. The frequencies of -607A/C, -137C/G 
and -133C/G genotypes in the healthy controls and plaque-induced gingivitis group were in 
accord with those expected by the Hardy-Weinberg equilibrium (P0.05). There were no 
significant differences in the allele and genotype frequencies between children with 
gingivitis and healthy controls (p = 0.35 and p = 0.90 for -607A/C, p=0.35 and p=0.89 for -
137C/G, and p=0.17 and p=0.57 for -133C/G variant, respectively, Table 3).  
 
  Genotypes of IL-18 -607A/C Alleles  
 N A/A (%) A/C (%) C/C (%) A C P 
Healthy gingiva 265 41 (15.5) 138 (52.1) 86 (32.4) 0.415 0.585  
Gingivitis 307 45 (14.7) 157 (51.1) 105 (34.2) 0.402 0.598 P = NS 
  Genotypes of IL-18 -137C/G Alleles  
 N C/C (%) C/G (%) G/G (%) C G P 
Healthy gingiva 265 28 (10.6) 112 (42.3) 125 (47.2) 0.317 0.683  
Gingivitis 307 29 (9.4) 129 (42.0) 149 (48.5) 0.305 0.695 P=NS 
  Genotypes of IL-18 -133C/G Alleles  
 N C/C (%) C/G (%) G/G (%) C G P 
Healthy gingiva 265 120 (45.3) 119 (44.9) 26 (9.8) 0.677 0.323  
Gingivitis 307 150 (48.9) 133 (43.3) 24 (7.8) 0.705 0.295 P=NS 
P - statistical significance for the comparison of genotype or allele frequencies between the two groups 
by 2-test (for genotypes) or Fisher’s exact test (for alleles). 
NS = non-significant differences 
Table 3. Genotype and allele frequencies of the IL-18 gene polymorphisms in controls and 
patients with gingivitis  
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As haplotype analyses may be of a higher informative value for drawing associations 
between phenotypes and genetic variation than SNPs, we also assessed haplotype 
frequencies using the SNPAnalyzer 2 program. Of eight haplotype combinations found, 
only three had frequency higher than 10% because all three variants in the IL-18 gene were 
in tight linkage disequilibrium with each other to various degrees (D´= from 0.656 to 0.786 
in controls and D´= from 0.726 to 0.790 in patients with plaque-induced gingivitis). We 
found no significant differences in frequency of the IL-18 haplotypes between children with 
gingivitis and control subjects (Table 4). 
 
 
      Haplotypes Healthy gingiva Gingivitis OR (95%CI) 
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C G C 0.510 0.521 1.05 (0.83-1.32) 
A C G 0.250 0.239 0.91 (0.69-1.19) 
A G C 0.117 0.119 1.00 (0.70-1.46) 
C G G 0.034 0.040 1.08 (0.55-2.10) 
A C C 0.027 0.037 1.37 (0.66-2.86) 
C C C 0.230 0.029 1.27 (0.62-2.59) 
A G G 0.021 0.016 0.86 (0.38-1.92) 
C C G 0.017 0.000 0.17 (0.02-1.47) 
                         P = NS   
NS = non-significant differences 
 
Table 4. The frequencies of the IL-18 haplotypes in both groups 
Possible links between genetic variants of IL-18 and microbiological colonization 
(occurrence of bacteria in gingival sulcus, including A. actinomycetemcomitans, P. gingivalis, P. 
intermedia, T. forsythia, T. denticola, P. micros, F. nucleatum, E. corrodens, A. viscosus, C. rectus, 
S.mitis, S. gordonii, P. nigrescens, S. constellatus, V. parvula, C. gingivalis, A. odontolyticus, C. 
concisus, E.nodatum, C. gracilis) were assessed in the subgroups of subjects (N=215). 
Although we found a significant difference in the occurrence of periodontal bacteria 
between the children with gingivitis and healthy controls ( P=0.00002 for P. gingivalis, 
P=0.0001 for A. actinomycetemcomitans, P=0.000001 for P. intermedia, P=0.000004 for F. 
nucleatum, P=0.0002 for A. odontolyticus, P=0.0009 for P. micros, P=0.007 for C. gingivalis, 
P=0.008 for C. gracilis, P=0.01 for S. constellatus, P=0.002 for S. mitis, and P=0.01 for C. rectus) 
(Table 5), no relationships between IL-18 variants and microbial pathogens were observed in 
any group (data not shown). 
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      Bacteria Healthy 
gingiva 
Gingivitis P level OR (95% CI) 
occurrence of bacteria 
in gingival sulcus (%) 
P. gingivalis 2.94 25.2 0.00002 11.11 (2.58-47.72) 
A. actinomycetemcomitans 35.3 64.0 0.0001 3.26 (1.78-5.98) 
P. intermedia 19.1 61.9 0.000001 6.87 (3.43-13.75) 
T. forsythia 1.5 5.0 NS 3.55 (0.43-29.48) 
T. denticola 2.9 7.9 NS 2.84 (0.61-13.17) 
P. micros 27.9 51.8 0.0009 2.77 (1.48-5.18) 
F. nucleatum 22.1 55.4 0.000004 4.39 (2.26-8.52) 
E. corrodens 77.9 82.7 NS 1.36 (0.66-2.79) 
A.viscosus 50.0 58.3 NS 1.40 (0.78-2.50) 
C. rectus 11.8 25.9 0.01 2.62 (1.14-6.01) 
S. mitis 76.5 92.1 0.002 3.58 (1.56-8.23) 
S. gordonii 80.9 86.3 NS 1.49 (0.69-3.24) 
P. nigrescens 4.4 9.4 NS 2.24 (0.61-8.13) 
S. constellatus 29.4 15.1 0.01 0.43 (0.21-0.86) 
V. parvula 38.2 49.6 NS 1.59 (0.88-2.88) 
C. gingivalis 16.2 33.1 0.007 2.56 (1.23-5.35) 
A.odontolyticus 29.4 56.1 0.0002 3.07 (1.65-5.70) 
C. concisus 0.0 3.6 NS * 
E. nodatum 0.0 1.4 NS * 
C. gracilis 1.5 11.5 0.008 8.72 (1.13-67.17) 
NS = non-significant difference 
*not applicable (small numbers) 
Table 5. Occurrence of bacteria in children with healthy gingiva and patients with gingivitis 
5.2.6 Discussion  
Plaque-induced gingivitis affects most children and adults. It is characterized by 
inflammation of the gingiva without loss of connective tissue attachment, alveolar bone or 
teeth. Given the multifactorial nature of inflammation and the major role of IL-18 in 
modulating immune functions, the possible association of polymorphisms in the IL-18 gene 
with plaque-induced gingivitis has been investigated. Previously we demonstrated no 
significant association of IL-18 -607A/C variant within the IL-18 gene with gingivitis 
(Vokurka et al., 2009). In a much larger (twice as large) study, we screened three IL-18 SNPs 
(at positions -607A/C, -137C/G, and -133C/G) alone and in combination (i.g. haplotypes) in 
Czech adolescents with and without plaque-induced gingivitis. We again failed to find any 
association of the three SNPs alone with gingivitis. In addition, no differences in haplotype 
frequencies were found between children with healthy gingiva and gingivitis and no 
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significant relationships between microbial pathogens, IL-18 polymorphisms and gingivitis 
were determined. Only three other studies have analyzed IL-18 gene variant in periodontal 
diseases. Folwaczny et al. (2005) did not find an association between several IL-18 
polymorphisms at positions -656, -607, -137, +113, +127 and codon 35/3 and periodontitis in 
Germany. The frequencies of the alleles and genotypes for -607A/C and -137C/G SNPs 
observed in their study were similar to our data both in healthy subjects and in children 
with gingivitis compared to patients with periodontitis. Indeed, some race/ethnicity-based 
differences exist in the relative frequencies of the IL-18 genotypes in non-Caucasian subjects 
(summary from Innate Immunity Programs for Genomic Applications, IIPGA database is 
available at http://www.innateimmunity.net). Two more recent studies (Noack et al. 2008, 
2009) analyzed associations of IL-18 polymorphisms at positions -368G/T and -838C/A 
(plus two TLR4 variants) with aggressive and chronic periodontitis  and failed to find an 
association between IL-18 polymorphisms and periodontal destruction. However, IL-18 
production is regulated on different levels of transcription, translation and post-translation. 
This may be the reason why, although the IL-18 gene is a plausible “candidate” gene for 
periodontal inflammation, simple phenotype-genotype association may be difficult to find.  
In conclusion, all to date published results reject the hypothesis that functionally relevant 
IL-18 gene variants have a major effect in periodontal disease – gingivitis, as well as chronic 
or aggressive periodontitis. Assuming that inflammation of gingival and periodontal 
destruction are multifactorial conditions, it would be interesting to study the impact of IL-18 
variants in a more complex genetic background of bacterial recognition and host response in 
gingivitis. 
6. General conclusions 
Inflammatory diseases of periodontium are one of the most common disorders in 
populations and together with dental caries are a major cause of tooth loss. Based on 
severity, intensity and location of the inflammatory process, it is possible to distinguish 
between gingivitis, and periodontitis. Inflammation of periodontal tissues may be associated 
not only with oral health but also with general state (mainly diabetes mellitus, cardio-
vascular diseases, pulmonary diseases, etc.), (Herzberg  Meyer, 1996, Taylor et al., 1996, 
Grossi  Genco, 1998, Persson GR  Persson RE, 2008, Williams et al., 2008).  
The origin of periodontal disease depends on the interaction of numerous endogenous and 
exogenous factors. The presence of a microbial plaque on the tooth surfaces initiates 
inflammation of the periodontal tissues. Periodontal pathogens are mainly anaerobic 
bacteria whose pathogenicity and virulence correlates with their quantity, biochemical and 
physical conditions within the sulcus or periodontal pocket and individual host’s 
responsiveness. The exact mechanisms of the disease development and progression have 
not been fully clarified yet. Gingivitis may, or may not, progress to periodontitis (Brown  
Löe, 1993). Today the great majority of these diseases are considered a multifactorial 
problem (a so-called complex disease) initiated and maintained by bacteria but significantly 
affected by a response of the individual (Kornman et al., 2000). Unlike monogenic diseases, 
gene variants participating in the development of complex diseases are not rare, distinctly 
pathogenic mutations. These are mostly “common“ variants of “normal“ genes (it means 
polymorphisms), often the most frequent alleles in population whose original (assumed) 
evolution advantage was lost under the condition of the current civilization.  
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Molecular and genetic research has not devoted much attention to periodontal diseases 
Although these diseases do not lead to premature death, study of their etiopathogenesis is 
very important as the high prevalence of periodontal diseases in population has very 
important social and economic consequences. Furthermore, we are not able to prevent the 
onset of these diseases in all individuals as primary preventive intervention is possible only 
after a detailed clarification of etiopathogenesis (thus also genetic determination of these 
diseases), which makes secondary preventive interventions even more urgent. This involves 
earlier diagnosis, mainly in the asymptomatic or incipient stages, efficient therapy and, last 
but not least, possibilities of determination of the individual’s risk for the development of 
more serious forms of the disease. 
The association between plaque-induced gingivitis and genetic polymorphisms has been 
studied on only seven genes in several studies, therefore it is difficult to conclude whether 
the analyzed polymorphisms can be involved in etiopathogenesis of gingivitis. Furthermore, 
there are several reasons for discrepancies in the findings reported in these studies: 
1. One of the main problems is very low “power of study” due to small sample sizes. Most 
associations refer to small odds ratios and relatively large confidence intervals which 
contributes to the risk for false positive or negative results.  
2. So far the most common case-control association study design is suitable for a lot of 
potential methodological problems connected with different definitions of clinical 
disease phenotype, different selections and definitions of control subjects, diversity of 
ethnic backgrounds of study samples etc. (Ioannidis, 2003). 
3. Because of the complexity of plaque-induced gingivitis and the large number of host 
derived and environmental/external factors involved in disease pathogenesis, it is 
logical to assume that multiple genetic variants (SNPs) on different genes may 
contribute to overall disease susceptibility. As such, a simple cause and effect 
relationship between a particular genetic allele and a disease is not possible. Therefore, 
rather than associations of the individual polymorphisms, combinations of 
polymorphisms in connection with other factors should be investigated by multivariate 
analyses.  
In conclusion, research on genetic polymorphisms in plaque-induced gingivitis has had 
limited success in unravelling significant and reproducible genetic factors for susceptibility 
to these diseases. Taken together the data published so far on gene variants in gingivitis, we 
can conclude that there is an insufficient number of studies to draw relevant conclusions. 
Nevertheless, the preliminary evidence suggests that polymorphisms in the IL-10, IL-1RN, 
IL-6 and MMP-9 may be associated with plaque-induced susceptibility. Results of genetic 
research, if verified in larger study cohorts, it could also lead to new diagnostic possibilities 
and help improve therapy of this disease or find parameters determining the risk of 
progression to more serious forms of periodontal disease. These findings could thus be a 
stimulus for an individual-based treatment approach and its optimization. Further clinical 
and genetic studies verifying the importance of these findings and their usability 
for monitoring of this disease activity still will have to be conducted. 
7. Acknowledgement 
This publication was supported by the project MSMT CR 1M0528 and by grant IGA 
NT11405-6. 
www.intechopen.com
 
Gingival Diseases – Their Aetiology, Prevention and Treatment 
 
230 
8. References  
Abecasis, G.R.; Cherny, S.S.; Cookson, W.O. & Cardon, L.R. (2002). Merlin-rapid analysis of 
dense genetic maps using sparse gene flow trees. Nat Genet, Vol.30, No.1, pp. 97-
101, ISSN 1061-4036  
Andus, T.; Daig, R.; Vogl, D.; Aschenbrenner, E.; Lock, G.; Hollerbach, S.; Köllinger, M.; 
Schölmerich, J.& Gross, V. (1997). Imbalance of the interleukin 1 system in colonic 
mucosa – association with intestinal inflammation and interleukin 1 receptor 
agonist genotype 2. Gut, Vol.41, No.5, pp. 651-657, ISSN 0017-5749 
Arimitsu, J.; Hirano, T.; Higa, S.; Kawai, M.; Naka, T.; Ogata, A.; Shima, Y.; Fujimoto, M.; 
Yamadori, T.; Hagiwara, K.; Ohgawara, T.; Kuwabara, Y.; Kawase, I. & Tanaka, T. 
(2006). IL-18 gene polymorphisms affect IL-18 production capability by monocytes. 
Biochim Biophys Res Commun, Vol.342, No.4, pp. 1413-1416, ISSN 0006-291X 
Armitage, G.C. (1999). Development of a classification system for periodontal diseases and 
conditions. Ann Periodontol, Vol.4, No.1, pp. 1-6, ISSN 1553-0841 
Assuma, R.; Oates, T.; Cochran, D.; Amar, S. & Graves, D.T. (1998). IL-1 and TNF 
antagonists inhibic the inflammatory response and bone loss in experimental 
periodontitis. J Immunol, Vol.160, No.1, pp. 403-409, ISSN 0022-1767 
Bawcock, A.M.; Kidd, J.R.; Lathrop, G.M.; Daneshvar, L.; May, LT.; Ray, A.; Sehgal, P.B.; 
Kidd, K.K. & Cavalli-Sforza, L.L. (1988). The human “interferon-beta 2/hepatocyte 
stimulating factor/interleukin-6” gene: DNA polymorphism studies and 
localization to chromosome 7p21. Genomics, Vol.3, No.1, pp. 8-16, ISSN 0888-7543. 
Birkedal-Hansen, H. (1993). Role of matrix metalloproteinases in human periodontal 
diseases. J Periodontol, Vol.64, No.5 Suppl., pp. 474-484, ISSN 0022-3492 
Beutler, B. & Grau, G.E. (1993). Tumor necrosis factor is the pathogenesis of infectious 
disease. Crit Care Med, Vol.21, No.10 Suppl., pp. S423-S435, ISSN 0090-3493 
Braun, N.; Michel, U.; Ernst, B.P.; Metzner, R.; Bitsch, A.; Weber, F. & Rieckamann, P. (1996). 
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-
alpha) in multiple sclerosis and it´s influence on the regulation of TNF-alpha 
production. Neurosci Lett, Vol.215, No.2, pp. 75-78, ISSN 0304-3940 
Brenan, C.J.; Roberts, D. & Hurley, J. (2009) Nanoliter high-throughput PCR for DNA and 
RNA profiling. Methods Mol Biol, Vol.496, pp. 161-174, ISSN 1064-3745 
Brew, K.; Dinakarpandian, D. & Nagase, H. (2000). Tissue inhibitors of metalloproteinases: 
Evolution, structure and fiction. Biochem Biophys Acta, Vol.147, No.1-2, pp. 267-283, 
ISSN 0006-3002 
Brown, L.I. & Löe, H. (1993). Prevalence, extent, severity and progression of periodontal 
disease. Periodontol 2000, Vol.2, pp. 57-71, ISSN 0906-6713   
Carroll, M.C.; Katzman, P.; Alicot, E.M.; Koller, B.H.; Geraghty, D.E.; Orr, H.T.; Strominger, 
J.L. & Spies, T. (1987). Linkage map of the human major histocompatibility complex 
including the tumor necrosis factor genes. Proc Natl Acad Sci USA, Vol.84, No.23, 
pp. 8535-8539, ISSN 0027-8424 
Clark, A.G.; Weiss, K.M.; Nickerson, D.A.; Taylor, S.L.; Buchanan, A.; Stengard, J.; Salomaa, 
V.; Vartiainen, E.; Perola, M.; Boerwinkle, E. & Sing, C.F. (1998). Haplotype 
structure and population genetic inferences from nucleotide-sequence variation in 
human lipoprotein lipase. Am J Hum Genet, Vol.63, No.2, pp. 595-612, ISSN 0002-
9297 
www.intechopen.com
 
Gene Polymorphisms in Gingivitis 
 
231 
Crawley, E.; Kay, R.; Sillibourne, J.; Patel, P.; Hutchinson, I. & Woo, P. (1999). Polymorphic 
haplotypes of the interleukin-10 5´-flanking region determine variable interleukin-
10 transcription and are associated with particular phenotypes of juvenile 
rheumatoid arthritis. Arthritis Rheum, Vol.42, No.6, pp. 1101-1108, ISSN 0004-3591 
Dashash, M.; Blinkhorn, A.S.; Hutchinson, I.V.; Pravica, V. & Drucker, D.B. (2005). The 
relationship between interleukin-10 gene polymorphism at position -1082 and 
susceptibility to gingivitis in children. J Periodontol, Vol.76, No.9, pp. 1455-1462, 
ISSN 0022-3492 
Dashash M.; Drucker, D.B.& Blinkhorn, A.S. (2006). Interleukin-10 haplotype frequencies in 
children with gingivitis. J Periodontol, Vol.77, No. 9, pp. 1503-1509, ISSN 0022-3492 
Dashash, M.; Drucker, D.B.; Hutchinson, I.V.; Bazrafshani, M.R. & Blinkhorn, A.S. (2007). 
Interleukin-1 receptor antagonist gene polymorphism and gingivitis in children. 
Oral Dis, Vol.13, No.3, pp. 308-313, ISSN 1354-523X 
Demacq, C.; Vasconcellos, V.B.; Marcaccini, A.M.; Gerlach, R.F.; Silva, W.A. Jr. & Tanus-
Santos, J.E. (2008). Functional polymorphisms in the promoter of the matrix 
metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 
variations in healthy subjects. Clin Chem Lab Med, Vol.46, No.1, pp. 57-63, ISSN 
1434-6621 
Delelau, N. & Bickel, M. (2004). Interleukin-1 beta and interleukin-18: regulation and activity 
in local inflammation. Periodontol 2000, Vol.35, No.1, pp. 42-52, ISSN 0906-6713 
Ferrari, S.L.; Ahn-Luong, L.; Garnero, P.; Humphries, S.E. & Greenspan, S.L. (2003). Two 
promoter polymorphisms regulating interleukin-6 gene expression are associated 
with circulating levels of C-reactive protein and markers of bone resorption in 
postmenopausal women. J Clin Endocrinol Metab, Vol.88, No.1, pp. 255-259, ISSN 
0021-972X 
Folwaczny, M.; Glas, J.; Török, H.P.; Tonenchi, L.; Paschos, E.; Bauer, B.; Limbersky, O. & 
Folwaczny, C. (2005). Polymorphisms of the interleukin-18 gene in periodontitis 
patients. J Clin Periodontol, Vol.32, No.5, pp. 530-534, ISSN 0303-6979 
Galbraith, G.M.; Hendley, T.M.; Sanders, J.J.; Palesch, Y. & Pandey, J.P. (1999). Polymorphic 
cytokine genotypes as markers of disease severity in adult periodontitis. J Clin 
Periodontol, Vol.26, No.11, pp. 705-709, ISSN 0303-6979 
Giedraitis, V.; He, B.; Huang, W.X. & Hillert, J. (2001). Cloning and station analysis of the 
human IL-18 promotere: a possible role fo polymorphisms in expression regulation. 
J Neuroimmunol, Vol.112, No.1-2, pp. 146-152, ISSN 0165-5728 
Goodson, J.M.; Plays, M.D. & Socransky, S.S. (2000). Gingival bleeding accentuated by 
plaque in healthy IL-1 (+) genotype subjects. J Dent Res, Vol.79, Abstract 221, p. 171, 
ISSN 0022-0345  
Grossi, S.G. & Genco, R.J. (1998). Periodontal disease and diabetes mellitus: a two-way 
relationship. Ann Periodontol, Vol.3, No.1, pp. 51-61, ISSN 1553-0841 
Hassell, T.M. & Harris, E.L. (1995). Genetic influences in caries and periodontal disease. Crit 
Rev Oral Biol Med, Vol.6, No.4, pp. 319-342, ISSN 1045-4411 
Herzberg, M. & Meyer, M. (1996). Effects of oral flora on platelets: possible concequences in 
cardiovascular disease. J Periodontol, Vol.67, No.10 Suppl., pp. 1138-1142, ISSN 
0022-3492 
www.intechopen.com
 
Gingival Diseases – Their Aetiology, Prevention and Treatment 
 
232 
Hoh, J.; Wille, A. & Ott, J. (2001). Trimming, weighting, and grouping SNPs in human case-
control association studies. Genome Res, Vol.11, No.12, pp. 2115-2119, ISSN 1088-
9051 
Hoh, J. & Ott, J. (2003). Mathematical multi-locus approaches to localizing complex human 
trait genes. Nat Rev Genet, Vol.4, No.9, pp. 701-709, ISSN 1471-0056 
Hurme, M. & Santtila, S. (1998). IL-1 receptor antagonist (IL-1Ra) plasma levels are co-
ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol, Vol.28, 
No.8, pp. 2598-2602, ISSN 0014-2980 
Ingman, T.; Tervahartiala, T.; Ding, Y.; Tschesche, H.; Haerian, A.; Kinane, D.F.; Konttinen, 
Y.T. & Sorsa, T. (1996) Matrix metalloproteinases and their inhibitors in gingival 
crevicular fluid and saliva of periodontitis patients. J Clin Periodontol, Vol.23, No.12, 
pp. 1127-1132, ISSN 0303-6979 
Ioannidis, J.P.A. (2003). “Genetic associations: false or true?” Trends Mol Med, Vol.9, No,4, 
pp. 135-138, ISSN 1471-4914 
Isaza-Guzmán, D.M.; Arias-Osorio, C.; Martínez-Pabón, M.C. & Tobón-Arroyave, S.I. (2011). 
Salivary levels of matrix metalloproteinase (MMP)-9 and tissue inhibitor of matrix 
metalloproteinase (TIMP)-1: A pilot study about the relationship with periodontal 
status and MMP-9(-1562C/T) gene promoter polymorphisms. Arch Oral Biol, 
Vol.56, No.4, pp. 401-411, ISSN 0003-9969  
Ishihara, Y.; Nishihara, T.; Kuroyanagi, T.; Shirozu, N.; Yamaghishi, E.; Ohguchi, M.; Koide, 
M.; Ueda, N.; Amano, K. & Noguchi, T. Gingival crevicular interleukin-1 and 
interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. 
J Periodontal Res, Vol.32, No.6, pp. 524-529, ISSN 0022-3484 
Izakovicova Holla, L.; Musilova, K.; Vokurka, J.; Klapusova, L.; Pantuckova, P.; Kukletova, 
M.; Kukla, L. & Znojil, V. (2008). Association of interleukin-6 (IL-6) haplotypes with 
plaque-induced gingivitis in children. Acta Odontol Scand, Vol.66, No.2, pp. 105-112, 
ISSN 0001-6357 
Jepsen, S.; Eberhard, J.; Fricke, D.; Hedderich, J.; Siebert, R. & Acil, Y. (2003). Interleukin-1 
gene polymorphisms and experimental gingivitis. J Clin Periodontol, Vol.30, No.2, 
pp. 102-106, ISSN 0303-6979 
Johansson, N.; Westermarck, J.; Leppä, S.; Häkkinen, L.; Koivisto, L.; López-Otín, C.; 
Peltonen, J.; Heino, J. & Kähäri, V.M. (1997). Collagenase 3 (matrix 
metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by 
tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ, 
Vol.8, No.2, pp. 243-250, ISSN 1044-9523 
Johnson, R.B. & Serio, F.G. (2005). Interleukin-18 and the pathogenesis of periodontal 
disease. J Periodontol, Vol.76, No.5, pp. 785-790, ISSN 0022-3492 
Kalina, U.; Ballas, K.; Koyama, N.; Kauschat, D.; Miething, C.; Arnemann, J.; Martin, H.; 
Hoelzer, D.; Ottmann, O.G. (2000). Genomic organization and regulation of the 
human interleukin-18 gene. Scand J Immunol, Vol. 52, No. 6, pp. 525-530, ISSN 0300-
9475 
Kobayashi, R.; Kono, T.; Bolerjack, B.A.; Fukuyama, Y.; Gilbert, R.S.;Fujihashi, K.; Ruby, J.; 
Kataoka, K.; Wada, M.; Yamamoto, M. & Fujihashi, K. (2011). Induction of IL-10-
producing CD4+ T-cells in chronic periodontitis. J Dent Res, Vol.90, No.5, pp. 653-
658, ISSN 0022-0345  
www.intechopen.com
 
Gene Polymorphisms in Gingivitis 
 
233 
Kornman, K.S.; Knobelman, C. & Wang, H.Y. (2000). Is periodontitis genetic? The answer 
may be Yes! J Mass Dent Soc, Vol.49, No.3, pp. 26-30, ISSN 0025-4800 
Koss, K.; Satsangi, J.; Fanning, G.C.; Welsh, K.I. & Jewell, D.P. (2000). Cytokine (TNF, LT 
and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: 
differential effects on production and allele frequencies. Genes Immun, Vol.1, No.3, 
pp. 185-190, ISSN 1466-4879 
Krohn, K.; Rozovsky, I.; Wals, P.; Teter, B.; Anderson, C.P. & Finch, C.E. (1999). Glial 
fibrillary acidic protein transcription responses to transforming growth factor-beta1 
and interleukin-1 beta are mediated by a nuclear factor-1-like site in the near-
upstream promoter. J Neuroimmunol, Vol.72, No.4, pp. 1353-1361, ISSN 0165-5728 
Kruse, S.; Kuehr, J.; Moseler, M.; Kopp, M.V.; Kurz, T.; Deichmann, K.A.; Foster, P.S. & 
Mattes, J. (2003). Polymorphisms in the IL-18 gene are associated with specific 
sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol, 
Vol.111, No.1, pp. 117-122, ISSN 0091-6749 
Kube, D.; Platzer, C.; von Knethen, A.; Straub, H.; Bohlen, H.; Hafner, M. & Tesch, H. (1995). 
Isolation of the human interleukin 10 promoter. Characterization of the promoter 
activity in Burkitt´s lymphoma cell lines. Cytokine, Vol.7, No.1, pp. 1-7, ISSN 1043-
4666 
Laine, M.L.; Loos, B.G.& Crielaard, W. (2010). Gene polymorphism in chronic periodontitis. 
Int J Dentistry, Vol.2010, Article ID 324719, 22 pages, ISSN 1687-8728 
Lander, E.S. & Schork, N.J. (1994). Genetic dissection of complex traits. Science, Vol.265, 
No.5181, pp. 2037-2048, ISSN 0036-8075 
Lang, N.P.; Tonetti, M.S.; Suter, J.; Sorrell, J.; Duff, G.W. & Kornman, K.S. (2000). Effect of 
interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding 
on probing in a periodontal maintenance population. J Periodontal Res, Vol.35, No.2, 
pp. 102-107, ISSN 0022-3484  
Lee, Y.H.; Kim, H.J.; Rho, Y.H.; Choi, S.J.; Ji, J.D. & Song, G.G. (2004). Interleukin-1 receptor 
antagonist gene polymorphism and rheumatoid arthritis. Rheumatol Int, Vol.24, 
No.3, pp. 133-136, ISSN 0172-8172  
Liang, X.H.; Chung, W. & Wang, D.Y. (2008). Differential and opposed transcriptional 
effects of interleukin-18 gene polymorphisms (-137, +113, and +127) in human 
HEpG-2, HeLa, U937, and THP-1 cells. Med Sci Monit, Vol.14, No.1, pp. BR8-BR13, 
ISSN 1234-1010  
Liu, B.; Li, S. & Hu, J. (2004). Technological advances in high-throughput screening. Am J 
Pharmacogenomics, Vol.4, No.4, pp. 263-276, ISSN 1175-2203  
Loe, H. Theilade, E. & Jensen, S.B. (1965). Experimental gingivitis in man. J Periodontol, 
Vol.36, pp. 177-187, ISSN 0022-3492 
Michalowicz, B.S. (1994). Genetic and heritable risk factors in periodontal disease. J 
Periodontol, Vol.65, No.5 Suppl., pp. 479-488, ISSN 0022-3492 
Müller, H.P. & Barrieshi-Nusair, K.M. (2007). A combination of alleles 2 of interleukin (IL)-
1A-889 and IL-1B+3954  is associated with lower gingival bleeding tendency in plaque-
induced gingivitis in young adults of Arabic heritage. Clin Oral Invest, Vol.11, No.3, 
297-302, ISSN 1432-6981 
Müller, H.P. & Barrieshi-Nusair, K.M. (2010). Site-specific gingival bleeding on probing in a 
steady-state plaque environment: Influence of polymorphisms in the interleukin-1 
gene cluster. J Periodontol, Vol.81, No.1, pp. 52-61, ISSN 0022-3492  
www.intechopen.com
 
Gingival Diseases – Their Aetiology, Prevention and Treatment 
 
234 
Müller-Steinhardt, E.; Ebel, B. & Härtel, C. (2007). The impact of interleukin-6 promoter -
597/-572/-174 genotype on interleukin-6 production after lipopolysaccharide 
stimulation. Clin Exp Immunol, Vol.147, No.2, pp. 339-345, ISSN 0009-9104  
Nishihara, T.; Ueda, N.; Amano, K.; Ishihara, Y.; Hayakawa, H.; Kuroyanagi, T.; Ohsaki, Y.; 
Nagata, K. & Noguchi, T. (1995). Actinobacillus actinomycetemcomitans Y4 capsular-
polysaccharide-like polysaccharide promotes osteoclast-like cell formation by 
interleukin-1 alpha production in mouse marrow cultures. Infect Immun, Vol.63, 
No.5, pp. 1893-1898, ISSN 0019-9567 
Niu, T.; Qin, Z.S.; Xu, X. & Liu, J.S. (2002). Bayesian haplotype inference for multiple linked 
single-nucleotide polymorphisms. Am J Hum Genet 2002, Vol.70, No.1, pp. 157-169, 
ISSN 0002-9297 
Niu, T. (2004). Algorithms for inferring haplotypes. Genet Epidemiol, Vol.27, No.4, 334-347, 
ISSN 0741-0395  
Noack, B.; Görgens, H.; Lorenz, K.; Ziegler, A.; Hoffmann, T. & Schackert, H.K. (2009). TLR4 
and IL-18 gene variants in aggressive periodontitis. J Clin Periodontol, Vol.35, No.12, 
pp. 1020-1026, ISSN 0303-6979 
Noack, B.; Görgens, H.; Lorenz, K.; Schackert, H.K. & Hoffmann, T. (2009). TLR4 and IL-18 
gene variants in chronic periodontitis: impact on disease susceptibility and severity. 
Immunol Invest, Vol.38, No.3-4, pp. 297-310, ISSN 0882-0139 
Nussbaum, R.L.; McInnes, R.R. & Willard, H.F. (2004) Klinická genetika (in Czech). W.B. 
Sounders Company, Philadelphia, Pennsylvania 2001, translation Goetz et al., 2004, 
Triton, pp. 1-426 
Nyholt, D.R. (2002) GENEHUNTER: your´one-stop shop´ for statistical genetic analysis? 
Hum Hered, Vol.53, No.1, pp.2-7, ISSN 0001-5652 
Ohlrich, E.J.; Cullinan, M.P. & Seymour, G.J. (2009). The immunopathogenesis of 
periodontal disease. Aust Dent J, Vol.54, No.1 Suppl., pp. S2-S10, ISSN 0045-0421 
Okamura, H.; Tsutsui, H.& Komatsu, T. (1995). Cloning of a new cytokine that induces IFN-
gamma production by T cells. Nature, Vol.378, No.6552, pp. 88-91, ISSN 0028-0836 
Orozco, A.; Gemmell, E.; Bickel, M. & Seymour, G.J. (2006). Interleukin-1 beta, interleukin-12 
and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and 
periodontitis. Oral Microbiol Immunol, Vol.21, No.4, pp. 256-260, ISSN 0902-0055 
Osiri, M.; McNicholl, J.; Moreland, J.W. & Bridges, S.L.Jun. (1999). A novel single nucleotide 
polymorphism and five probable haplotypes in the 5´flanking region of the IL-6 
gene in African-Americans. Genes Immun, Vol.1, No.2, pp. 166-167, ISSN 1466-4879 
Ota, N.; Hunt, S.C.; Nakajima, T.; Suzuki, T.; Hosoi, T.; Orimo, H.; Shiray, Y. & Emi, M. 
(1999). Linkage of interleukin 6 locus to human osteopenia  by sibling pair analysis. 
Hum Genet, Vol.105, No.3, pp. 253-257, ISSN 0340-6717 
Panagakos, F.S. & Kumar, S. (1995). Differentiation of human osteoblastic cells in culture: 
modulation of proteases by extracellular matrix and tumor necrosis factor-alpha. 
Inflammation, Vol.19, No.4, pp. 423-443, ISSN 0360-3997 
Papanicolaou, D.A.; Wilder, R.L.; Manolagas, S.C. & Chrousos, G.P. (1998). The 
pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med, Vol.128, 
No.2, pp. 127-137, ISSN 0003-4819  
Persson, G.R. & Persson, R.E. (2008). Cardiovascular disease and periodontitis: an update on 
the association and risk. J Clin Periodontol, Vol.35, No.8 Suppl., pp. 362-379, ISSN 
0303-6979 
www.intechopen.com
 
Gene Polymorphisms in Gingivitis 
 
235 
Pociot, E.; Molvig, J.; Wogensen, L.; Worsaae, H.& Nerup, J. (1992) A TaqI polymorphism in 
the human interleukin-1 (IL-1) gene correlates with IL-1 secretion in vitro. Eur J 
Clin Invest, Vol.22, No.6, pp. 396-402, ISSN 0014-2972 
Qin, Z.S.; Niu, T. & Liu, J.S. (2002). Partition-ligation-expectation-maximization algorithm 
for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet, 
Vol.71, No.5, pp. 1242-1247, ISSN 0002-9297 
Roberts, F.A.; Hockett, R.D. Jr.; Bucy, R.P. & Michalek, S.M. (1997). Quantitative assessment 
of inflammatory cytokine gene expression in chronic adult periodontitis. Oral 
Microbiol Immunol, Vol.12, No.6, pp. 336-344, ISSN 0902-0055 
Rawlinson, A.; Dalati, M.H.; Rahman, S.; Walsh, T.F. & Fairclough, A.L. (2000). Interleukin-1 
and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol, Vol.27, 
No.10, pp. 738-743, ISSN 0303-6979 
Salem, R.M.; Wessel, J. & Schork, N.J. (2005). A comprehensive literature review of 
haplotyping software and methods for use with unrelated individuals. Hum 
Genomics, Vol.2, No.1, pp. 39-66, ISSN 1473-9542 
Scapoli, Ch.; Tatakis, D.N.; Mamolini, E. & Trombelli, L. (2005). Modulation of clinical 
expression of plaque-induced gingivitis: Interleukin-1 gene cluster polymorphisms. 
J Periodontol, Vol.76, No.1, pp. 49-56, ISSN 0022-3492 
Scapoli, C.; Mamolini, E. & Trombelli, L. (2007). Role of IL-6, TNF-A and LT-A variants in 
the modulation of the clinical expression of plaque-induced gingivitis. J Clin 
Periodontol, Vol.34, No.12, pp. 1031-1038, ISSN 0303-6979 
Scarel-Caminaga, R.M.; Trevilatto, P.C.; Souza, A.P.; Brito, R.B.; Camargo, L.E. & Line, S.R. 
(2004). Interleukin 10 gene promoter polymorphisms are associated with chronic 
periodontitis. J Clin Periodontol, Vol.31, No.6, pp. 443-448, ISSN 0303-6979 
Seymour, G.J.; Gemmell, E.; Walsh, L.J. & Powell, R.N. (1988). Immunohistological analysis 
of experimental gingivitis in humans. Clin Exp Immunol, Vol.71, No.1, pp. 132-137, 
ISSN 0009-9104 
Shapira, L.; Wilensky, A. & Kinane, D.F. (2005). Effect of genetic variability on the 
inflammatory response to periodontal infection. J Clin Periodontol, Vol.32, No.Suppl. 
6, pp. 72-86, ISSN 0303-6979   
Shi, M.M. (2002) Technologies for individual genotyping: detection of genetic 
polymorphims in drug targets and disease genes. Am J Pharmacogenomics, Vol.2, 
No.3, pp. 197-205, ISSN 1175-2203 
Shiroddria, S.; Smith, J.; McKay, I.J.; Kennett, C.N. & Hughes, F.J. (2000). Polymorphisms in 
the IL-1A gene are correlated with levels of interleukin-1 protein in gingival 
crevicular fluid of teeth with severe periodontal disease. J Dent Res, Vol.79, No.11, 
pp. 1864-1869, ISSN 0022-0345  
Sobel, E. & Lange, K. (1996). Descent graphs in pedigree analysis: applications to 
haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet, Vol.58, 
No.6, pp.1323-1337, ISSN 0002-9297 
Stephens, M.; Smith ,N.J. & Donnelly, P. (2001). A new statistical method for haplotype 
reconstruction from population data. Am J Hum Genet, Vol.68, No.4, pp. 978-989, 
ISSN 0002-9297 
Stephens, M. & Donelly. P. (2003). A comparison of bayesian methods for haplotype 
reconstruction from population genotype data. Am J Hum Genet, Vol.73, No.5, pp. 
1162-1169, ISSN 0002-9297 
www.intechopen.com
 
Gingival Diseases – Their Aetiology, Prevention and Treatment 
 
236 
Takashiba, S. & Naruishi, K. (2006). Gene polymorphisms in periodontal health and disease. 
Periodontol 2000, Vol.40, pp. 94-106, ISSN 0906-6713 
Taylor, G.W.; Burt, B.A.; Becker, M.P.; Genco, R.J.; Shlossman, M.; Knowler, W.C. & Pettitt, 
D.J. (1996). Severe periodontitis and risk for poor glycemic control in patients with 
non-insulin-dependent diabetes mellitus. J Periodontol, Vol.67, No.10 Suppl., pp. 
1085-1093, ISSN 0022-3492 
Terry, C.F.; Loukaci, V. & Green, F.R. (2000). Cooperative influence of genetic 
polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem, Vol.275, 
No.24, pp. 18138-18144, ISSN 0021-9258  
Tilg, H.; Trehu, E.; Atkins, M.B.; Dinarello, C.A. & Mier, J.W. (1994). Interleukin-6 (IL-6) as 
an anti-inflammatory cytokine: induction of interleukin-1 receptor antagonist and 
soluble tumor necrosis factor receptor p55. Blood, Vol.83, No.1, pp. 113-118, ISSN 
0006-4971 
Tregouet, D.A.; Escolano, S.; Tiret, L.; Mallet, A. & Goldmard, J.L. (2004). A new algorithm 
for haplotype-based association analysis. The Stochastic-EM algorithm. Ann Hum 
Genet, Vol.68, No.Pt.2, pp. 165-177, ISSN 0003-4800 
Tsuchihashi, Z. & Dracopoli, N.C. (2002). Progress in high throughput SNP genotyping 
methods. Pharmacogenomics J, Vol.2, No.2, pp. 103-110, ISSN 1470-269X 
Turner, D.M.; Williams, D.M.; Sankaran, D.; Lazarus, M.; Sinnott, P.J. & Hutchinson, I.V. 
(1997). An investigation of polymorphismin the interleukin-10 gene promoter. Eur J 
Immunogenet, Vol. 245, No. 1, pp. 1-8, ISSN 0960-7420. 
Vokurka, J.; Klapusova, L.; Pantuckova, P.; Kukletova, M.; Kukla, L. & Holla, L.I. (2009). The 
association of MMP-9 and IL-18 gene promoter polymorphisms with gingivitis in 
adolescents. Arch Oral Biol, Vol. 54, No.2, pp. 172-178, ISSN 0003-9969.  
Westendorp, R.G.; Langermans, J.A.; Huizinga, T.W.; Verweij, C.L. & Sturk, A. (1997). 
Genetic influence on cytokine production and fatal meningococcal disease. Lancet, 
Vol.349, No.9069, pp. 1912-1913, ISSN 0140-6736  
Williams, R.C.; Barnett, A.H.; Claffey, N.; Davis, M.; Gadsby R.; Kellett M.; Lip, G.Y. & 
Thackray, S. (2008). The potential impact of periodontal disease on general health: a 
consensus view. Curr Med Res Opin, Vol.24, No.6, pp. 1635-1643, ISSN 0300-7995 
Yoshie, H.; Kobayashi, T.; Tai, H.& Galicia, J.C. (2007). The role of genetic polymorphisms in 
periodontitis. Periodontol 2000, Vol.43, pp. 102-132, ISSN 0906-6713 
Zhang, B.; Ye, S.; Hermann, S.M.; Eriksson, P.; de Maat, M.; Evans, A.; Arveiler, D.; Luc, G.; 
Cambien, F.; Hamsten, A.; Watkins, H. & Henney, A.M. (1999). Functional 
polymorphism in the regulatory region of gelatinase B gene in relation to severity 
of coronary atherosclerosis. Circulation, Vol.99, No.14, pp. 1788-1794, ISSN 0009-
7322 
www.intechopen.com
Gingival Diseases - Their Aetiology, Prevention and Treatment
Edited by Dr. Fotinos Panagakos
ISBN 978-953-307-376-7
Hard cover, 230 pages
Publisher InTech
Published online 22, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Gingival diseases are a family of distinct pathological entities that involve the gingival tissues. These signs and
symptoms of these diseases are so prevalent in populations around the world that they are often considered to
be â€œnormalâ€ ​ features. The diseases are now classified into two main groups namely: Plaque-Induced and
Non-Plaque Induced Gingival Diseases. This book provides dentists, dental hygienists, dental therapists and
students with a comprehensive review of gingival diseases, their aetiology and treatment.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Lydie Izakovicova Holla, Kristina Musilova, Jan Vokurka, Pavla Pantuckova, Lubomir Kukla, Martina Kukletova
and Zdenek Broukal (2011). Gene Polymorphisms in Gingivitis, Gingival Diseases - Their Aetiology, Prevention
and Treatment, Dr. Fotinos Panagakos (Ed.), ISBN: 978-953-307-376-7, InTech, Available from:
http://www.intechopen.com/books/gingival-diseases-their-aetiology-prevention-and-treatment/gene-
polymorphisms-in-gingivitis
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
